143 results about "Serum triglycerides" patented technology

The invention relates to highly concentrated DHA and EPA formulations in a soft gel capsule. A capsule may contain at least 80% omega-3 fatty acids, salts or derivatives thereof, where EPA and DHA are present in relative amounts of greater than or equal to 3:1 or less than or equal to 1:3, and constitute at least 75% to greater than 95% of the total fatty acids present in the capsule. Capsules of the invention may be provided in a blister package so as to provide clean and protected oils that are easy to travel with. Compliance is improved with one-pill-a-day dosing and the days of the week imprinted on the foil packing. Anitoxidant protection may be provided by rosemary and vitamin C. The invention also provides a methods of treatment, modulation or prophalaxis of coronary disease, altering serum LDL-cholesterol and / or HDL-cholesterol, lowering serum triglycerides, lowering blood pressure, pulse rate, altering the activity of the blood coagulation factor VII complex, mild hypertension, protection from cyclosporine toxicity in kidney transplant, rheumatoid arthritis, development and progression of retinopathy, hypertriglyceridemia, and neurological disorders in a subject.

The invention belongs to the technical field of affinal drug and diet formulas and new resource food, and particularly provides blood fat-reducing medical science formula food, specific medical formula food or non-specific medical formula food. The formula food is prepared by performing reasonable compatibility on multiple affinal drug and diet traditional Chinese medicines according to the traditional Chinese medicine essence theory and mixing drug-diet dual purpose traditional Chinese medicine extract essence extracted through a semi-bionic extraction method, multiple microencapsulated probiotics, oligopeptides extracted through biological enzymolysis, prebiotics, amino acid, carbohydrate, fat with a health-care function, multiple vitamins and mineral substances according to the requirements of a 'special medial-purpose formula food general rule' by combining the constitutive characters of hyperlipidemia patients; the formula food not only can serve as a single nutrition source to meet the nutritional requirement of the hyperlipidemia patients, but also achieves the effects of reducing total cholesterol, reducing serum triglyceride, reducing an atherosclerosis index, reducing blood pressure, reducing blood sugar, reducing fat to lose weight and enhancing the immunity.

The invention provides in one embodiment a method for treating vascular trauma. The method can include administering to an individual undergoing vascular trauma an effective amount of a retinoic acid receptor (RAR) antagonist or an RAR inhibitor. The methods can be used to lower serum triglycerides in a patient undergoing an invasive vascular procedure such as vascular surgery.

The invention provides a production technology of a blood lipid reducing lotus leaf tea, pertaining to the tea processing technical field. Fresh lotus leaves are cut into squares with a side length of 4cm, laid open on a conveyer belt of a 6CW-10E type tea microwave de-enzyming and drying device for being treated with de-enzyming of the lotus leaves, laid for cooling for 20min, put into a 6CR-30 type tea roller for rolling for 20-40min based on a principle of 'light-heavy-light', then the lotus leaves are laid open on the conveyer belt evenly for drying and cooling, crushed through 40 meshes and packaged into tea bags. The production process of the lotus tea provided by the invention adopts microwave technology for de-enzyming and drying the lotus leaves, which greatly shortens the production time of the lotus leaf tea, improves the production efficiency and enhances preservation of flavone substances in the lotus leaves. Water soluble lotus leaf flavone contained in the tea soup of the lotus leaf tea is not less than 0.23mg / g, thereby being capable of reducing serum triglyceride and total cholesterol remarkably and having auxiliary function for reducing blood lipid.

Evidence is emerging that lipid accumulation in the liver and the muscle contributes to insulin resistance in type II diabetes and the metabolic syndrome (1). This has prompted an investigation of the relationship between lipid accumulation in the liver, serum triglyceride levels, and glucose disposal. These studies demonstrate that liver fat positively correlated to fasting triglyceride levels and negatively correlated to glucose diposal (2). Therefore, strategies to prevent lipid accumulation in liver would have therapeutic value for treatment of type II diabetes, metabolic syndrome and non-alcoholic fatty liver disease. The invention described here relates to continuous administration of GLP-1 or its analogs obtained by either gene or cell therapy that results in reduction serum triglycerides and reduction of lipid accumulation in the liver for treatment of type II diabetes, the metabolic syndrome or non-alcoholic fatty liver disease.

The invention discloses lactobacillus gasseri and application thereof in relieving and treating hyperuricemia, and belongs to the technical field of microorganisms. According to the lactobacillus gasseri CCFM1133 disclosed by the invention, the serum uric acid level of hyperuricemia mice and the xanthine oxidase (XOD) activity of serum and a liver can be reduced, and the occurrence of hyperuricemia and gout is reduced; the blood glucose and serum triglyceride (TG) level of a patient with hyperuricemia can be regulated, and the activity of liver catalase (CAT) and glutathione peroxidase (GSH-Px) is improved; expression of ileum ABCG2 is improved, and excretion of intestinal uric acid is promoted; and the intestinal short-chain fatty acid level is improved, and the health is promoted. The lactobacillus gasseri CCFM1133 disclosed by the invention can be used for preparing foods, functional foods or medicines, and has a wide application prospect.

The invention describes therapeutic compositions including a lactic acid-producing bacteria, such as isolated Bacillus coagulans, in combination with a bifidogenic oligosaccharides or other cholesterol-reducing agents for use in reducing LDL cholesterol and serum triglycerides. Also described are therapeutic methods using the compositions and systems containing the therapeutic compositions.

The invention discloses a fructus rosae laevigatae healthy oral solution for reducing blood fat. The healthy oral solution is prepared from the following medicinal raw materials in parts by weight: 10-50 parts of fructus rosae laevigatae, 10-20 parts of radices trichosanthis, 10-20 parts of hawthorn, 10-20 parts of pollen typhae, 10-20 parts of exocarpium benincasae, 10-20 parts of evening primrose, 10-20 parts of radix rehmanniae recen, 10-20 parts of glossy privet fruit, 10-20 parts of polygonum cuspidatum, 10-20 parts of radix polygoni multiflori preparata, 10-20 parts of gynostemma pentaphylla, 10-20 parts of astragalus membranaceus, 10-20 parts of poria cocos, 10-20 parts of radix paeoniae rubra, 10-20 parts of pericarpium citri reticulatae and 10-20 parts of salviae miltiorrhizae, wherein fructus rosae laevigatae contains fatty acid, 3-sitosterol, tannin, saponin and the like, is capable of reducing blood fat and reducing deposition of fat in blood vessels, and can be used for treating atherosclerosis; and traditional Chinese medicinal materials with effects of activating blood circulation to remove stasis and remarkably reducing fat and serum triglyceride are capable of improving micro-circulation. The medicinal materials are mostly tasted fresh, cannot influence the flavor of fructus rosae laevigatae, can be easily accepted by people, and can reach a relatively good blood fat reducing effect.

The invention provides tartary buckwheat tea capable of losing weight, reducing lipid and relaxing bowels, and a preparation method of the tea. The tea comprises the following materials by weight parts: 10-50 parts of tartary buckwheat, 10-20 parts of purslane, 10-20 parts of hyacinth bean flowers, 10-20 parts of dried radix rehmanniae, 10-20 parts of cortex lycii radicis, 10-20 parts of lalang grass rhizome, 10-20 parts of poria cocos, 10-20 parts of the root of red-rooted salvia, 10-20 parts of lotus leaves,10-20 parts of eupatorium, 10-20 parts of gynostemma pentaphylla, 10-20 parts of cortex mori radicis, 10-20 parts of dogwood, 10-20 parts of radix curcumae, 10-20 parts of rhizoma cyperi, 10-20 parts of astragalus membranaceus, 10-20 parts of barley, 10-20 parts of atractylodes macrocephala koidz, 10-20 parts of hawthorns and 10-20 parts of leonurus. The tartary buckwheat has the functions of gut purging, intestine lubricating and bowel relaxing, can influence the internal lipid metabolism, and can obviously reduce cholesterol in the serum and the liver; as traditional Chinese medicinal materials capable of promoting blood circulation to remove blood stasis and obviously reducing fat and serum triglyceride are added, after the tea is drunk for a long time, the microcirculation can be improved; the traditional Chinese medicinal materials are light in taste, the taste of the tartary buckwheat tea can not be influence and can be received by people easily, and the effects of losing the weight and reducing the lipid can be relatively well realized.

The invention discloses a preparation method and application of water-insoluble xylan. The preparation method comprises the following steps: extracting xylan from plant cell walls with an alkali liquid, removing most of the alkali liquid, and performing deep purification and bleaching treatment on a water-insoluble part, thereby obtaining edible water-insoluble xylan, wherein purities are separated and purified through multiple times of replacement and ultra filtration with diluted alkali water of a specific pH value, the pH value of a turbid emulsion to 8-13 with an acid, further replacementwashing is carried out through a centrifugation or micro-filtration membrane, no alcohol is used in the whole process, only a product of water-insoluble xylan is generated, soluble components are completely removed, and the purity content of the water-insoluble xylan can be up to 85-90%. The water-insoluble xylan prepared by using the method has the functions of promoting intestinal health, inhibiting starch decomposition or absorption, reducing serum cholesterol, reducing serum triglyceride, treating constipation, treating fatty livers and improving processing properties of rice and wheat flour foods.

The invention provides a lipid-lowering and pressure-releasing folium ginkgo health-care product. The health-care product comprises the following raw materials in part by weight: 50-100 parts of folium ginkgo, 10-20 parts of fructus rubi, 10-20 parts of rehmannia glutinosa, 10-20 parts of Chinese angelica, 10-20 parts of dogwood, 10-20 parts of radix salviae miltiorrhizae, 10-20 parts of poria cocos, 10-20 parts of dracocephalum heterophyllum benth, 10-20 parts of codonopsis pilosula, 10-20 parts of herba eupatorii, 10-20 parts of gynostemma pentaphylla, 10-20 parts of astragalus mongholicus, 10-20 parts of rhizoma alismatis, 10-20 parts of safflower carthamus, 10-20 parts of scutellaria baicalensis, 10-20 parts of radix paeoniae alba, 10-20 parts of gardenia, 10-20 parts of white atractylodes rhizome, 10-20 parts of glossy privet fruit, 10-20 parts of tartary buckwheat and 10-20 parts of propolis. According to the invention, as the folium ginkgo is extracted, the active ingredients of the folium ginkgo are retained, and the toxicity is reduced; and as the traditional Chinese medicinal materials, which can activate blood and remove stasis and can obviously reduce the blood sugar and fat serum triglyceride, are added, the microcirculation can be improved, the immunity is enhanced, and people can accept easily, as a result, the lipid-lowering and pressure-releasing efficacy can be better achieved. According to the invention, the health-care product cannot be taken by pregnant women and young children.

The invention discloses traditional Chinese medicine composition for treating hyperlipidaemia. The composition comprises raw materials in parts by weight as follows: 10-15 parts of red-rooted salvia roots, 15-20 parts of turmeric, 12-18 parts of bighead atractylodes rhizome, 16-22 parts of poria cocos, 10-15 parts of eucommia ulmoides, 5-10 parts of wild jujube leaves, 12-18 parts of scutellaria baicalensis, 15-20 parts of curcuma aromatica, 10-15 parts of rhizoma cyperi, 5-10 parts of radix scrophulariae, 10-15 parts of loranthus parasiticus, 8-14 parts of Chinese wampee leaves, 5-10 parts of rhizoma alismatis, 6-12 parts of semen cassiae, 10-15 parts of astragalus membranaceus, 5-10 parts of semen coicis, 10-15 parts of yellow lotus flowers, 8-14 parts of fructus psoraleae, 10-15 parts of Chinese yams, 12-18 parts of rhizoma atractylodis, 15-20 parts of potentilla discolor, 6-12 parts of polygonum multiflorum, 10-15 parts of radix rehmanniae preparata, 5-10 parts of jujubes, 10-15 parts of grapefruit flowers, 8-14 parts of sealwort and 10-15 parts of glossy privet fruits. The composition is reasonable in formula, definite in efficacy, obvious in synergistic effect on reduction of serum total cholesterol, serum triglyceride and low-density lipoprotein cholesterol and increase of high-density lipoprotein cholesterol, obvious in anti-hyperlipidemic effect, effective in treatment, instant in effect, short in treatment course, high in cure rate, small in toxic and side effects and applicable to various diseases caused by the hyperlipidaemia.

The invention discloses a single reagent serum triglyceride detection reagent with strong stability, and belongs to the technical field of clinical in-vitro detection. The reagent adopts a 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)-sodium glutamate buffer system, so that the system has a good buffer capacity; triethanolamine lauryl sulfate, a coenzyme FAD, polyvinyl alcohol AH-26 and other substances are added in the reagent and all effectively improve the stability of the reagent. Compared with a conventional single reagent triglyceride detection reagent, the reagent has more excellent stability and is more conducive to clinical popularization and use.

The invention relates to flavored fermented milk with a healthcare probiotic function and a making method of the flavored fermented milk. The flavored fermented milk comprises the following raw materials parts by weight: 900-980 parts of raw milk, 50-100 parts of white sugar, 10-50 parts of whey protein powder, 5-15 parts of starch, 1-10 parts of xylooligosaccharide, 0.01-0.16 part of a fermentation agent with lactobacillus bulgaricus and streptococcus thermophilus, and 0.04-0.32 part of lactobacillus gasseri. The flavored fermented milk provided by the invention is made of fermentation agentbacteria with probiotic functions through fermentation, and a probiotic bacterium, namely lactobacillus gasseri with a good intestinal tract immobilization property, and prebiotics with proliferationeffects on the probiotic bacteria, are used, so that the product has remarkable healthcare probiotic function characteristics of preventing and relieving constipation, reducing total levels of cholesterol, reducing lipoprotein concentrations, reducing levels of serum triglyceride, and reducing the weight of patients suffering from obesity.

The night taken Tibetan medicine for treating diabetes is prepared with bear bile, emblic, saffron, artificial musk, amur barberry bark and other four kinds of medicinal materials, and through grinding into fine powder and mixing in certain weight proportion. It may be prepared into bolus, medicine powder, soft capsule or granule. The Tibetan medicine can lower blood sugar and lower serum triglyceride, and has also obvious curative effect on nephrosis. It has fast absorption of the effective components in the medicine and high curative effect.

The invention discloses acanthopanax health tea for decreasing sugar and lipid. The acanthopanax health tea is prepared from the following raw material medicines in parts by weight: 10-50 parts of acanthopanax, 10-20 parts of gynostemma pentaphyllum, 10-20 parts of roots of red-rooted salvia, 10-20 parts of dried rehmannia roots, 10-20 parts of jasmines, 10-20 parts of rhizoma alismatis, 10-20 parts of lotus leaves, 10-20 parts of scutellaria baicalensis, 10-20 parts of Chinese waxgourd peel, 10-20 parts of roots of common peony, 10-20 parts of radix trichosanthis, 10-20 parts of cortex moutan, 10-20 parts of selfheal, 10-20 parts of dandelions, 10-20 parts of fructus forsythia and 10-20 parts of Chinese violets. The acanthopanax health tea is a completely green, healthy and environment-friendly health product. The acanthopanax health tea can be used for promoting and balancing the fat metabolism of the human body to achieve effects of reducing blood fat, reversing obesity and the like, and is exact in effects of reducing weight, relaxing the bowels, expelling toxin and promoting the sleep. The traditional Chinese medicines with effects of promoting blood circulation to remove blood stasis and obviously reducing fat and serum triglyceride are added, so that the acanthopanax health tea can be used for improving micro circulation, reducing sugar, reducing fat and reducing weight, is easy to accept by people and achieves a daily health function.

The invention provides a soft capsule health food capable of protecting the liver. The food is characterized by comprising squalene and soybean lecithin soft capsules and plant oil. The invention further provides a preparation method and application of the health food. According to the food, squalene is compounded with soybean lecithin, so that the content of rat serum triglyceride and malondialdehydle of an alcohol model can be remarkably reduced and the content of reduced glutathione in hepatic tissues is increased, which fully shows that a squalene and soybean lecithin compound has a remarkable protection effect on alcohol-induced liver damage; therefore, the protection effect on chemical liver damage can be improved. Compared with single soyabean lecithin, the squalene and soybean lecithin compound has a better protection effect on chemical liver damage.

Analysis of full-blood glucose, serum insulin, serum triglycerides and total serum cholesterol were performed. Glucose levels in blood samples from the oral glucose tolerance test were used for calculation of the incremental Area Under the Curve (AUC0-120 min-baseline). All data are expressed as percentage change of vehicle treated animals (cf. FIGS. 1 and 2).

The invention discloses a health care product capable of sobering up and protecting liver, in particular to oral preparations, such as disintegrating tablets, effervescent tablets, beverage and the like of the health care product and a preparation method thereof. The health care product is an oral preparation papered from raw material and carrier or excipient capable of being accepted by human body, wherein the raw material comprises 1-5 parts of Hovenia dulcis Thunb supercritical extractive, 1-5 parts of Chinese wisteria supercritical extractive, 0.1-1 part of taurine and 1-3 parts of mixture of vitamin B complex and vitamin C complex. Meanwhile, the invention also discloses the disintegrating tablet, the effervescent tablet, beverage and the preparation method. The health care product of the invention can better improve drunkenness symptom, total effective rate is averagely 90.0%, 90.1% and 91.7%. The effect experiment of animal blood fat and ant-oxidation system shows that the comparative difference of content of animal liver malondialdehyde, reducing glutathione and serum triglyceride and a control group has the statistical significance.

Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-γ by adipose tissue.

The invention discloses a Chinese herbal composition for preventing or treating hyperlipemia, which relates to the technical field of Chinese herbal medicines. The Chinese herbal composition is prepared from the following active components by weight: 12 to 16 parts of lotus leaves, 15 to 20 parts of mulberry leaves, 15 to 20 parts of chrysanthemum, 8 to 12 parts of sophora flower, 12 to 16 parts of spine date seeds, 12 to 16 parts of raspberry, 15 to 20 parts of cassia seeds, 8 to 12 parts of wrinkled giant hyssop, 8 to 12 parts of Poria cocos, 8 to 12 parts of red sage root, 12 to 16 parts of dried orange peel and 15 to 20 parts of peach seeds. The Chinese herbal composition provided in the invention has an obvious synergistic effect on reducing serum total cholesterol, serum triglycerides and low density lipoprotein cholesterol and is advantageous in improving high density lipoprotein cholesterol.

The invention relates to a blood-sugar reducing tea and a preparation method thereof. The blood-sugar reducing tea is prepared by taking guava leaves, flos notoginseng, fructus momordicae and jasmine flowers as the materials through the steps of selecting the materials and removing impurities as well as rotten and deteriorated materials, then drying under 50-85 DEG C, cracking, and screening through vibrating screen; and then taking 20-60 meshes of materials, mixing, sterilizing and packaging the materials according to proportions. The blood-sugar reducing tea and the preparation method thereof have the advantages of unique composing prescription, confirmed curative effect, convenient use, economy, safety and no side effect, has the effects of clearing heat and promoting the secretion of saliva or body fluid, reducing sugar and removing fat, dispersing stagnation and dredging collaterals, and is applicable to patients with abnormal sugar tolerance and diabetics to use. Experiment research shows that the blood-sugar reducing tea and the preparation method thereof have the effects of reducing blood sugar and lightening insulin resistance, increasing insulin sensitivity, protecting Beta cell functions, and reducing serum total cholesterol and serum triglyceride without toxic side effects.

Solid, free-flowing, and substantially completely dissolvable preparations with high betalain content are presented. Most typically, the betalain profile of the preparations is near natural and includes betalains in an amount of between 10-40 wt %. As the preparations of the inventive subject matter maintain chemical stability and flowability over extended periods of time, it should be noted that the betalain preparations are now amenable to compounding in small and measured quantities. Furthermore, new biological activities of betalains are shown, and especially include significant induction of SIRT and reduction of serum triglyceride.

The invention provides gardenia blood-glucose-reducing and lipid-reducing healthcare tea. The gardenia blood-glucose-reducing and lipid-reducing healthcare tea is prepared from, by weight, 10-50 parts of gardenia, 10-20 parts of root of rehmannia, 10-20 parts of prunella vulgaris, 10-20 parts of eucommia ulmoides, 10-20 parts of angelica sinensis, 10-20 parts of astragalus membranaceus, 10-20 parts of rhizome sparganii, 10-20 parts of gynostemma pentaphylla, 10-20 parts of root bark of white mulberry, 10-20 parts of loofah sponge, 10-20 parts of dogwood, 10-20 parts of curcuma aromatica, 10-20 parts of Artemisia anomala, 10-20 parts of semen cassiae, 10-20 parts of bighead atractylodes rhizome, 10-20 parts of hawthorn, 10-20 parts of root bark of peony trees and 10-20 parts of glossy privet fruit. According to modern medical research, gardenia can cool the blood and expel toxins, clear away blood waste and promote metabolism of in vivo cells; the traditional Chinese medicine materials which can promote the blood circulation to remove blood stasis and have the obvious reducing effects on lipid and serum triglyceride are added, the traditional Chinese medicine materials are mostly light in taste and do not influence the fresh and gentle flower taste of the gardenia, and the healthcare tea can be easily accepted by people and can well achieve the effects of reducing lipid and blood glucose.

The invention discloses a medical composition for treating metabolic syndromes, belonging to the field of medicines, and in particular relates to a medical composition containing orlistat or cetilistat and heparin, wherein the composition is solid preparations such as compressed tablets, dispersible tablets, sustained release tablets, capsules, granules, and the like. In experiments, the medical composition containing the orlistat or the cetilistat and the heparin is accidentally found to have obvious synergistic effect on the aspects of reducing the blood pressure, the serum total cholesterol, the serum triglyceride and the low density lipoprotein cholesterin and enhancing the carbohydrate tolerance.

The invention relates to blood sugar reducing healthy tea and a preparation method thereof. The blood sugar reducing healthy tea is prepared by the following steps: using guayaba leaves, cassia bark, momordica grosvenori and jasmine tea as raw materials; cleaning and removing impurities and rotten bad raw materials, drying at 50-85 DEG C and crushing, sieving by a vibration sieve; taking 20-60mu of raw materials, mixing according to the proportion, sterilizing and packaging. The invention has the advantages of special formulation, accurate treatment effect, convenient use, low cost and safety without toxic and side effects, has the functions of clearing heat and enriching the saliva, tonifying spleen and resolving dampness, and reducing blood sugar and lipid, and is suitable to patients with abnormal glucose tolerance and mild diabetes mellitus. Tests show that the invention has the functions of reducing blood sugar, lightening insulin resistance, increasing the sensitivity of insulin, protecting the function of Beta cells, and lowering serum total cholesterin and serum triglyceride without toxic and side effects.

The invention provides great burdock achene healthcare tea for reducing blood glucose and lipid. The great burdock achene healthcare tea for reducing blood glucose and lipid comprises the following raw materials in parts by weight: 10-50 parts of great burdock achene, 10-20 parts of radix rehmanniae preparata, 10-20 parts of poria cocos, 10-20 parts of salviae miltiorrhizae, 10-20 parts of angelica sinensis, 10-20 parts of astragalus, 10-20 parts of fortune eupatorium herb, 10-20 parts of gynostemma pentaphyllum, 10-20 parts of cortex mori radicis, 10-20 parts of towel gourd vegetable sponge, 10-20 parts of cornus officinalis, 10-20 parts of curcuma aromatica, 10-20 parts of artemisia anomala, 10-20 parts of semen cassia, 10-20 parts of white atractylodes rhizome, 10-20 parts of pyrrosia lingua, 10-20 parts of herba houttuyniae, 10-20 parts of cynanchum paniculatum, and 10-20 parts of solomonseal rhizome. Modern medical research proves that the great burdock achene can reduce content of serum total cholesterol and triacylglycerol, can clear blood garbage and promote metabolism of body cells; the traditional Chinese medicinal materials for promoting blood circulation to remove blood stasis and obviously reducing fat and serum triglyceride are added, and most of the medicinal materials are light in taste, and easy to accept by people, and can better achieve the effects of reducing blood glucose and lipid, and the taste of the great burdock achene tea is not affected.

The invention discloses a medical composition for treating metabolic syndromes, belonging to the field of medicines, and in particular relates to a medical composition containing orlistat or cetilistat and actos, wherein the composition is solid preparations such as compressed tablets, dispersible tablets, sustained release tablets, capsules, granules, and the like. In experiments, the medical composition containing the orlistat or the cetilistat and the actos is accidentally found to have obvious synergistic effect on the aspects of reducing the blood pressure, the serum total cholesterol, the serum triglyceride and the low density lipoprotein cholesterin and enhancing the carbohydrate tolerance.

The invention relates to the field of medicines, and specifically relates to a medicine composition and an application thereof. The medicine composition is mainly composed of a first component and a second component, wherein the first component is total saponins of astragalus, and the second component is angelica sinensis volatile oil; or the first component is astragaloside, and the second component is ferulic acid. The medicine composition is applied to preparing medicines for preventing and / or treating atherosclerosis. The medicine composition has significant effect on reducing serum cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterin and serum triglyceride, and improving a cardiac function ejection fraction, so that the medicine composition has the efficacy of preventing or treating hyperlipemia. Therefore, atherosclerosis and cardiovascular and cerebrovascular diseases are prevented and treated.